CATX vs ECL
Perspective Therapeutics Inc. (CATX) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Perspective Therapeutics Inc. (CATX) is a medical devices company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported CATX revenue for 2023-09-30 was $2.2M. Net income was -$10.4M. Revenue was up 4.6% from 2023-06-30 to 2023-09-30. CATX currently screens at market cap $280.6M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
CATX currently screens at market cap $280.6M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the CATX and ECL stock pages for the full models.
Not investment advice.